Foundation Fighting Blindness
Foundation Fighting Blindness
Add to My Podcasts
Episodes
About
Reviews
Promote
Sepul Bio’s LCA10 RNA Therapy Moves into Phase 3 Clinical Trial
3 minutes
Posted Oct 2, 2025 at 4:56 pm.
0:00
3:20
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
The emerging therapy improved vision for some participants in an earlier clinical trial.
Previous
Opus Reports Vision Improvements for Three Pediatric Patients in Phase 1/2 Clinical Trial for LCA5 Gene Therapy
Next
Eye on the Cure Podcast | Episode 93: Sam Seavey
← See all 261 episodes of Foundation Fighting Blindness